This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.00% per year. These returns cover a period from January 1, 1988 through May 4, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
insurance: Archive
Top Stock Reports for Berkshire Hathaway, AstraZeneca & Intel
by Mark Vickery
Berkshire Hathaway's shares have edged past its industry, backed by insurance growth, rising float, strong cash and expanding investments, including Japan.
communications finance insurance medical semiconductor
PRU Stock Trades at Discount to Industry at 7.62X: Time to Hold?
by Zacks Equity Research
Prudential Financial gains from solid asset-based businesses, strong demand for retirement products and global expansion.
insurance
MTG Outperforms Industry, Hits 52-Week High: How to Play the Stock
by Zacks Equity Research
MGIC Investment gains from strong new business, healthier housing activity, declining claims and robust capital.
insurance
UNH vs. ELV: Which Managed Care Stock Has the Edge Today?
by Rajshree Sipani
Elevance Health is edging past UnitedHealth as Carelon's growth, strategic exits and a cheaper valuation shape a stronger near-term setup.
artificial-intelligence dental finance healthcare hospitals insurance insurance-premium medical smart-health
Hartford Insurance Up 27% in a Year: Does the Rally Still Have Legs?
by Zacks Equity Research
HIG is up nearly 27% in a year as earnings, revenue growth and capital returns power the rally, but leverage and Personal Insurance risks still linger.
finance insurance
Here's Why Investors Should Hold on to AON Shares Right Now
by Zacks Equity Research
AON is poised for steady growth, backed by strong estimate revisions, organic expansion and disciplined capital returns despite debt risks.
finance insurance
Why Humana Deserves Patience Now: Too Early to Buy, Too Risky to Sell
by Zacks Equity Research
HUM sits at a crossroads as Medicare Advantage pressures cap near-term upside, but resilience versus peers argues for patience, not panic.
insurance medical
3 Insurers to Buy Heading Into 2026 as High Rates Boost Yields
by Tanuka De
High bond yields and disciplined underwriting are set to boost the earnings power of MCY, HRTG and RNR in 2026.
insurance
Implied Volatility Surging for Principal Financial Stock Options
by Zacks Equity Research
Investors need to pay close attention to PFG stock based on the movements in the options market lately.
insurance
Take the Zacks Approach to Beat the Markets: Castle Biosciences, Hamilton Insurance & Monster Beverage in Focus
by Santanu Roy
Castle Biosciences surged 77.9% after a Zacks upgrade, highlighting how the firm's stock picks outpaced the broader market in recent months.
aerospace construction consumer-staples finance gold insurance medical multi-sector-conglomerates pharmaceuticals